Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
RADIOPHARMACEUTICAL REQUEST, ILLUCCIX FOR PROSTATE CANCER IMAGING is a federal award for 262-Network Contract Office 22 (36C262) held by Telix Pharmaceuticals (Us) Inc. Estimated value $543K ($186K obligated). Current period of performance ends Nov 6, 2023. Last award drew 1 bidder. Place of performance: DUBLIN OH.
RADIOPHARMACEUTICAL REQUEST, ILLUCCIX FOR PROSTATE CANCER IMAGING
Recompete timing
PublicCurrent PoP ended Nov 6, 2023 (1019 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordTelix Pharmaceuticals (Us) Inc — $6.9M obligated across 17 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C26223F0064?
36C26223F0064 (Radiopharmaceutical request illuccix for) is a 262-Network Contract Office 22 (36C262) award with a potential value of $543K, currently held by Telix Pharmaceuticals (Us) Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C262-23-F-0064?
36C262-23-F-0064 is the dashed form of PIID 36C26223F0064 (Radiopharmaceutical request illuccix for), held by Telix Pharmaceuticals (Us) Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C26223F0064?
262-Network Contract Office 22 (36C262) awarded 36C26223F0064 to Telix Pharmaceuticals (Us) Inc (potential $543K).
Who is the incumbent on 36C26223F0064?
Telix Pharmaceuticals (Us) Inc is the incumbent with $6.9M across 17 related awards in SCOUT’s public footprint. The current period of performance ends Nov 6, 2023.
When does Telix Pharmaceuticals (Us) Inc’s 36C26223F0064 come up for recompete?
SCOUT tracks a period-of-performance end of Nov 6, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
